Post-hoc analysis | Could SGLT2 inhibitors have a beneficial effect on gout symptoms?

Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid–Lowering Therapy and Colchicine in Patients With Heart Failure With and Without GoutA Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER – JAMA Cardiology

Related: Post-hoc analysis | Can SGLT2 inhibitors reduce the risk of hyperuricemia and gout?